McGill International TB Centre receives $17.2 M for clinical trials and clinical research on tuberculosis
RI-MUHC researcher Dick Menzies leads international network to fight TB
$9.6M federal infrastructure investment renews Canada’s largest study of aging
Congratulations to Dr. Christina Wolfson, a Senior Scientist at the RI-MUHC...
COVID-19 in prisons: understanding the spread of the disease
Since the start of the pandemic, COVID-19 rates in Canadian correctional facilities have been...
INESSS honours McGill team for contributions to pandemic hospital projections
Public health researchers David Buckeridge and Mathieu Maheu-Giroux lead valuable support initiative
Suzanne Morin named to CIHR Institute Advisory Board
RI-MUHC researcher promotes musculoskeletal health for Canadians
Jason Harley appointed Director of Research at the Steinberg Centre for Simulation and Interactive Learning
Enhancing health sciences education, supporting healthcare workers
Overcoming vaccine hesitancy
Our best hope of charting a course to a post-pandemic world
Early diagnosis is key to prevention of potentially fatal complication in type 1 diabetes
New RI-MUHC study of international data suggests awareness and access to care are key factors in improving...
New study of hydroxychloroquine usage may help personalize lupus treatment
RI-MUHC researchers identify factors associated with poor outcomes for lupus patients
Saliva samples for COVID-19 testing: as good as nasopharyngeal swabs, but cheaper
New meta-analysis of 37 studies and over 7,000 paired saliva and nasopharyngeal swab samples